---
schema_version: "secwatch.filing_event.v1"
accession: "0001171520-22-000351"
form_type: "8-K"
ticker: "CLPT"
cik: "0001285550"
company_name: "ClearPoint Neuro, Inc."
filed_at: "2022-05-26T23:59:59+00:00"
generated_at: "2026-06-25T06:39:11.288865+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# ClearPoint Neuro stockholders approve authorized share reduction from 200M to 80M

## Summary
- Authorized common shares reduced from 200M to 80M via Certificate of Amendment.
- Eight directors elected, including Joseph Burnett, R. John Fletcher, and Matthew Klein.
- Cherry Bekaert LLP ratified as independent auditor for FY 2022; 15.8M for, 19.6K against.
- Fourth Amended and Restated 2013 Incentive Compensation Plan approved (8.7M for).
- Advisory vote on executive compensation approved with 8.6M for, 887K against.

## SEC filing metadata
- accession: 0001171520-22-000351
- form_type: 8-K
- ticker: CLPT
- cik: 0001285550
- company_name: ClearPoint Neuro, Inc.
- filed_at: 2022-05-26T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1285550/000117152022000351/0001171520-22-000351-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1285550/000117152022000351/eps10282.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171520-22-000351
- JSON: https://secwatch.observer/filing/0001171520-22-000351.json
- Plain text: https://secwatch.observer/filing/0001171520-22-000351.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.